Evidence map›Paper›PMID 31290266›Full record

ArticleAging cell2019

Peroxisome proliferator-activated receptor γ coactivator 1α regulates mitochondrial calcium homeostasis, sarcoplasmic reticulum stress, and cell death to mitigate skeletal muscle aging.

Jonathan F Gill, Julien Delezie, Gesa Santos, Shawn McGuirk, Svenia Schnyder, Stephan Frank, Martin Rausch, Julie St-Pierre, Christoph Handschin

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.Journal of cachexia, sarcopenia and muscle · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Chaperone Proteins: The Rising Players in Muscle Atrophy.Journal of cachexia, sarcopenia and muscle · 2025
    Review
  9. Effects of aging on calcium channels in skeletal muscle.Frontiers in molecular biosciences · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Ginsenoside Rc, an Active Component ofAntioxidants (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jonathan F GillBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, Basel, Switzerland.
Julien DelezieBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, Basel, Switzerland.
Gesa SantosBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, Basel, Switzerland.
Shawn McGuirkDepartment of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, Quebec, Canada.
Svenia SchnyderBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, Basel, Switzerland.
Stephan FrankDivision of Neuropathology, Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
Martin RauschBiotherapeutic and Analytical Technologies, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.
Julie St-PierreDepartment of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, Quebec, Canada.
Christoph HandschinBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, Basel, Switzerland.ORCID 0000-0003-0603-1097
University of Basel · CHMcGill University Health Centre · CANovartis (Switzerland) · CH

Funding

European Research Council 616830"Fellowships for Excellence", International PhD Program of the BiozentrumFonds de Recherche du Québec - SantéFP7 Ideas: European Research Council 616830-MUSCLE_NETSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungSwiss Cancer Research KFS-3733-08-2015Swiss National Science Foundation 156654Swiss Society for Research on Muscle DiseasesSystemsX.chVanier Canada Graduate Scholarship, Canadian Institutes of Health Research
6 · The paper itself

Abstract

Age-related impairment of muscle function severely affects the health of an increasing elderly population. While causality and the underlying mechanisms remain poorly understood, exercise is an efficient intervention to blunt these aging effects. We thus investigated the role of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a potent regulator of mitochondrial function and exercise adaptation, in skeletal muscle during aging. We demonstrate that PGC-1α overexpression improves mitochondrial dynamics and calcium buffering in an estrogen-related receptor α-dependent manner. Moreover, we show that sarcoplasmic reticulum stress is attenuated by PGC-1α. As a result, PGC-1α prevents tubular aggregate formation and cell death pathway activation in old muscle. Similarly, the pro-apoptotic effects of ceramide and thapsigargin were blunted by PGC-1α in muscle cells. Accordingly, mice with muscle-specific gain-of-function and loss-of-function of PGC-1α exhibit a delayed and premature aging phenotype, respectively. Together, our data reveal a key protective effect of PGC-1α on muscle function and overall health span in aging.

Indexed as

HomeostasisStress, PhysiologicalAgingAnimalsCalciumCell DeathMaleMiceMice, Inbred C57BLMitochondriaMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSarcoplasmic ReticulumCalciumPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseagingcalcium homeostasiscell deathhealth spanmitochondriaPGC-1αskeletal muscletubular aggregates

Identifiers

PMID31290266
PMCPMC6718523
OpenAlexW2958433391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.